A US study has shown that netarsudil (Rhopressa) can offer additional intraocular pressure (IOP)-lowering effects in patients on maximally tolerated medical therapies for glaucoma. After reviewing
ValenzaBio’s monoclonal antibody drug to treat thyroid eye disease (TED) has been cleared by the US Food and Drug Administration to enter phase 1a clinical trials. The drug, VB421, targets the
A biomedical engineer at Western Sydney University has developed gloves with sensors that record the subtle differences between experienced and trainee surgeons’ actions.
Two-year outcomes in an Australian study comparing the implantation of iStent inject with Hydrus Microstent, found the iStent afforded a small additional reduction in glaucoma medication usage following cataract surgery compared with the Hydrus.
US-based ophthalmic pharmaceutical firm Eyenovia released details of its latest study demonstrating that its Optejet eyedrop dispenser reduced conjunctival cell toxicity from preserved ophthalmic solutions to a level comparable with non-preserved solutions.
Auckland-based consultant ophthalmologists and researchers Professors Charles McGhee and Helen Danesh-Meyer have both been named in The Ophthalmologist’s prestigious annual Power List. The list highlights the, “Top 100 most influential people in the world of ophthalmology” and is selected by an inte
This year’s New Zealand #LoveYourEyes campaign, led by Eye Health Aotearoa (EHA) and supported by the International Agency for the Prevention of Blindness (IAPB), is calling on the government to urgently conduct New Zealand’s first eye health survey.
Utah is the latest US state to submit a bill to allow optometrists to perform procedures including laser capsulotomy, laser trabeculoplasty and laser peripheral iridotomy. If it passes, Utah will become the ninth US state to extend optometrists’ scope of practice to include laser, joining Alaska, Ar
A Danish study has found Marfan syndrome (MFS) is associated with “a profound burden of ocular morbidity”. An inherited disorder that affects connective tissue, typical MFS symptoms include tall and slender build, disproportionately long arms, legs and fingers, and myopia.
Swiss-start-up Biped has developed a smart harness which has been designed to act as an artificial intelligence (AI) co-pilot for blind and visually impaired people.
Johnson & Johnson Vision has launched the Tecnis Eyhance Toric II intraocular lens (IOL) with Tecnis Simplicity Delivery System, a next-generation monofocal IOL for cataract patients with astigmatism.
Retinal specialist Dr Sophie Hill has joined the team at Eye Institute.